Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study.
Conclusions: The majority of CHC patients had comorbidities; almost all patients took multiple prescribed medications, the number of which increased with age, and significant DDI risk was present in 97% of this Korean patient cohort. Comorbidities and comedication profiles should be considered during DAA therapy.
PMID: 32616682 [PubMed - as supplied by publisher]
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetic Ulcers | Endocrinology | Gastroenterology | Health Insurance | Hepatitis | Hepatitis C | Hypertension | Insurance | Liver | Peptic Ulcer | Study | Urology & Nephrology